McKesson's most recent trend suggests a bearish bias. One trading opportunity on McKesson is a Bear Call Spread using a strike $139.00 short call and a strike $144.00 long call offers a potential 28.21% return on risk over the next 10 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $139.00 by expiration. The full premium credit of $1.10 would be kept by the premium seller. The risk of $3.90 would be incurred if the stock rose above the $144.00 long call strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for McKesson is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for McKesson is bearish.
The RSI indicator is at 37.03 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for McKesson
Chuck Norris sues med-tech companies, including one in Twin Cities
Fri, 03 Nov 2017 20:00:16 +0000
Actor and martial arts star Chuck Norris has sued several pharmaceutical and med-tech companies, including Eden Prairie-based Acist Medical Systems, over a chemical used in magnetic resonance imaging scans. Gena and Chuck Norris filed the lawsuit Wednesday in San Francisco Superior Court, saying use of the chemical gadolinium in MRI scans poisoned Gena Norris. The couple is seeking unspecified damages and coverage of past and future medical expenses, which the Norrises said totaled more than $2 million over the past five years.
Ohio AG gives McKesson, others 30 days to be ‘part of the solution' on addictive opioids
Wed, 01 Nov 2017 20:44:34 +0000
Ohio's attorney general fired off letters to the CEOs of five makers of pain-killing opioid drugs and the leaders of other healthcare companies, including San Francisco-based wholesaler McKesson Corp., to force accountability for the state's opioid epidemic. Attorney General Mike DeWine's letters Monday aren't the first moves aimed at rolling back addiction to opioids, a class of drugs that includes prescription painkillers, such as oxycodone, and the street-level drugs heroin and fentanyl. What's more, President Donald Trump last week declared the opioid epidemic a national public health emergency, including an ad campaign.
ETFs with exposure to McKesson Corp. : November 1, 2017
Wed, 01 Nov 2017 16:22:37 +0000
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to McKesson Corp. Here are 5 ETFs with the largest exposure to MCK-US. Comparing the performance and risk of McKesson Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name … Read more
BG Staffing And Other Great Cheap Stocks
Wed, 01 Nov 2017 13:02:28 +0000
Stocks recently deemed undervalued include BG Staffing and McKesson, as they trade at a market price below their true valuations. Smart investors can make money from this discrepancy by buyingRead More…
Missouri attorney general demands opioid distributor records
Tue, 31 Oct 2017 23:45:21 +0000
JEFFERSON CITY, Mo. (AP) — Missouri Attorney General Josh Hawley on Tuesday said he's demanding documents from three major opioid distributors that he claims didn't report suspiciously large shipments of prescription drugs.
Also on Market Tamer…
Follow Us on Facebook